SCHEMBL6219967

SCHEMBL6219967

CCN=C(N)N[C@H]1CC[C@@H](C(NC(=O)c2ccccc2OC)c2ccccc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
HPGD P15428 1/20 0.47
MEN1 O00255 1/20 0.44
MAPK1 P28482 1/20 0.44
KMT2A Q03164 1/20 0.44
KCNA5 P22460 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
KCNA3 P22001 7/20 0.42
CTSD P07339 1/20 0.41
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41
TAS1R2 Q8TE23 1/20 0.41
KCNK3 O14649 1/20 0.40
SLC6A12 P48065 1/20 0.39
ATM Q13315 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5468220 0.89 KCNA3 (0.44) ALDH1A1HPGDMEN1MAPK1KMT2A
SCHEMBL6219970 0.83 MEN1 (0.47) ALDH1A1HPGDMEN1MAPK1KMT2A
SCHEMBL3455507 0.81 MEN1 (0.62) ALDH1A1HPGDMEN1MAPK1KMT2A
SCHEMBL5345113 0.76 ALDH1A1 (0.41) ALDH1A1HPGDMEN1MAPK1KMT2A
SCHEMBL5353631 0.75 KCNA3 (0.75) ALDH1A1MEN1KMT2AKCNA3
SCHEMBL5353627 0.75 KCNA3 (0.75) ALDH1A1MEN1KMT2AKCNA3
SCHEMBL6221527 0.75 ALDH1A1 (0.46) ALDH1A1HPGDMEN1MAPK1KMT2A
SCHEMBL5457922 0.74 ALDH1A1 (0.45) ALDH1A1HPGDMEN1MAPK1KMT2A
SCHEMBL2857658 0.74 KMT2A (0.55) ALDH1A1HPGDMEN1MAPK1KMT2A
SCHEMBL6220580 0.73 ALDH1A1 (0.44) ALDH1A1HPGDMEN1MAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1507504-A1 CYCLOALKYL INHIBITORS OF POTASSIUM CHANNEL FUNCTION Bristol-Myers Squibb Company (US) 2005-02-23 EP disclosed
WO-2003063797-A2 CYCLOALKYL INHIBITORS OF POTASSIUM CHANNEL FUNCTION BRISTOL-MYERS SQUIBB COMPANY (US) 2003-08-07 WO disclosed